J Neurosci Nurs (2007) 39:402.10.1097/01376517-200702000-00008 82 HsiaoFCHungYJHsiehCHWuLYShihKCHeCT
Clinical formulations typically incorporate appropriate antioxidant buffers or maintain GHK-Cu concentrations within therapeutic windows (0.1-10 M) to optimize beneficial effects while minimizing pro-oxidant risks
But apart from that, tesamorelin also has a lower risk profile than BPC-157 and CJC-1295, which two peptides pose a danger of immunogenicity causing your body to mount an immune response as though they were pathogens.9 With tesamorelin, theres no reported risk of immunogenicity
When Do You Inject CJC-1295/Ipamorelin
For example, if your protocol calls for 250mcg daily for 30 days, and you reconstituted with 2 mL of bacteriostatic water, each 0.1 mL withdrawal contains a specific amount
Inactivation of muscle insulin and IGF-I receptors and insulin responsiveness